Search

everythinglearnresearchcommunity

for

Search:↓

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Cepharanthine shows promise as a COVID-19 treatment.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

Common dermatology drugs were considered but are controversial for COVID-19 treatment.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Natural products might help treat COVID-19, but current drugs like hydroxychloroquine haven't worked.

People with androgenetic alopecia had milder COVID-19 symptoms during the Omicron wave in China.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Androgens play a key role in causing alopecia by changing the hair growth cycle.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Low TRPS1 expression in skin and hair cells is linked to hair problems in Trichorhinophalangeal syndrome.

PRS injections can improve knee function and reduce pain for up to a year.

The MEST method increases cell yield and volume for regenerative medicine but needs more testing.

Trps1 plays a key role in hair follicle development and cycling.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

Sox13 is a marker for early hair follicle development but not essential for skin and hair growth.

TRF1 is crucial for creating and maintaining stem cells and marks both pluripotent and adult stem cells.

Platelet-Rich Plasma (PRP) helps reduce jaw pain and improve function in young adults with mild TMJ disorder.

A new mutation in the MBTPS2 gene causes a mild form of IFAP syndrome.

Lack of FPR2 slows hair growth by affecting hair cell activity.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

Overexpressing the human H-ferritin gene in mice causes mild growth delay and temporary hair loss.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

Hair shedding that lasts over 6 months may need a closer look, but often just reassurance is enough.

Hair shedding that lasts more than 6 months may need medical tests, but often just reassurance is enough.

Temporary scalp trichopigmentation creates a shaved hair look on the scalp using pigments that fade over time.